Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]

Crit Care. 2005;9(6):R790-7. doi: 10.1186/cc3911. Epub 2005 Nov 16.

Abstract

Introduction: Strict control of plasma glucose in diabetic and non-diabetic patients has been shown to improve outcome in several clinical settings. There is extensive evidence that glucose can stimulate the production of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-alpha and IL-6, with no effect on the anti-inflammatory cytokine IL-10. We hypothesized that strict glucose regulation results in a change in cytokine balance from a pro-inflammatory state to a more balanced anti-inflammatory condition. In a randomized controlled trial we studied the effect of strict glycemic control on the local and systemic pro-inflammatory and anti-inflammatory balance in non-diabetic patients undergoing elective coronary artery bypass grafting with cardiopulmonary bypass.

Methods: After surgery patients were randomly assigned to intensive insulin therapy (blood glucose between 80 and 110 mg/dl) or conventional insulin therapy (blood glucose less than 200 mg/dl). At 0, 1, 2, 4, 8, 12, 16 and 24 hours after admission to the intensive care unit, plasma samples and samples from the mediastinal drains were obtained. We measured the concentrations of the pro-inflammatory cytokines TNF-alpha and IL-6 and the anti-inflammatory cytokine IL-10 by enzyme-linked immunosorbent assay.

Results: Both patient groups were comparable in demographics, clinical characteristics and peri-operative data. In the intensive treatment group, glucose levels were significantly lower than in the conventionally treated group. No differences were found between both groups in the concentrations of TNF-alpha, IL-6 and IL-10 in plasma samples or in fluid draining the mediastinal cavity. Levels of IL-6 and IL-10 were significantly higher in mediastinal fluid samples than in plasma samples, suggesting a compartmentalized production of cytokines.

Conclusion: The protective effect of intensive insulin therapy in patients after cardiac surgery with cardiopulmonary bypass is not related to a change in cytokine balance from a pro-inflammatory to an anti-inflammatory pattern. Systemic cytokine levels are not representative of the local inflammatory response.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Blood Glucose / drug effects
  • Body Fluids / metabolism
  • Coronary Artery Bypass / adverse effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Inflammation / drug therapy*
  • Inflammation / etiology*
  • Inflammation / metabolism
  • Insulin / therapeutic use*
  • Interleukin-10 / metabolism
  • Interleukin-6 / metabolism
  • Male
  • Mediastinum
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10

Associated data

  • ISRCTN/ISRCTN95608630